Table 3 |
||||||
|
Results of univariate analyses for disease versus controls |
||||||
| Polymyositis |
Dermatomyositis |
|||||
|
|
||||||
| HLA phenotype |
p |
pcorr |
OR (95% CI) |
p |
pcorr |
OR (95% CI) |
|
|
||||||
| DRB1*03 |
6 × 10-12 |
7 × 10-11 |
4.3 (2.8–6.7) |
2 × 10-04 |
0.003 |
2.2 (1.4–3.5) |
| DRB1*07 |
4 × 10-04 |
0.005 |
0.3 (0.2–0.6) |
0.03 |
NS |
1.7 (1.04–2.6) |
| DQA1*02 |
0.004 |
0.02 |
0.3 (0.1–0.7) |
0.06 |
NS |
1.7 (0.96–3.2) |
| DQA1*05 |
1 × 10-08 |
9 × 10-08 |
4.6 (2.6–8.3) |
0.01 |
0.06 |
2.0 (1.2–3.4) |
| DQB1*02 |
4 × 10-05 |
2 × 10-04 |
2.9 (1.7–4.9) |
5 × 10-05 |
3 × 10-04 |
2.9 (1.7–5.0) |
|
|
||||||
|
CI, confidence interval; NS, not significant; OR, odds ratio; p, probability; pcorr, corrected probability. |
||||||
|
Chinoy et al. Arthritis Research & Therapy 2006 8:R13 doi:10.1186/ar1862 |
||||||
